Lake Street Maintains Buy on Yield10 Bioscience, Lowers Price Target to $3
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Ben Klieve maintains a 'Buy' rating on Yield10 Bioscience (NASDAQ:YTEN), but has lowered the price target from $12 to $3.
August 16, 2023 | 5:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Despite the 'Buy' rating maintained by Lake Street, the significant reduction in price target from $12 to $3 could negatively impact investor sentiment towards Yield10 Bioscience.
Analyst ratings and price targets can significantly influence investor sentiment and stock prices. While the 'Buy' rating is positive, the drastic reduction in price target could indicate potential concerns about the company's future performance, which may negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100